Posts

Showing posts with the label kidney stone

mild hyperparathyroidism: not need surgery

Image
  A recent long-term follow-up study suggested that observation was as good as parathyroidectomy in patients with mild primary hyperparathyroidism (see hyperparathyroid surgery no better AIM2022 in dropbox or doi:10.7326/M21-4416 )   Details:  -- 191 patients with mild hyperparathyroidism in eight Scandinavian referral centers were randomly assigned to parathyroidectomy (PTX) versus observation (OBS), from 1998 to 2005 -- baseline: mean age 63, 83% women, BP 140/80, prevalent vertebral fractures 7%, history of peripheral fractures 25% -- history of cardiovascular disease 13%/cancer 4%/kidney stone 3%, mean corrected calcium 10.6 mg/dL, mean PTH 91 ng/L, mean creatinine 0.9 mg/dL (no comment on phosphate level) -- data and causes of death were obtained from the Swedish and Norwegian registries 10 years after randomization and also after an extended observation period lasting to 2018; morbidity events were prospectively registered annually -- inclusion criter...

Tamsulosin ineffective for kidney stones??? Not so fast...

​ A recent article suggested that tamsulosin was ineffective in improving kidney stone passage, for stones up to 9mm (see kidney stone tamsulosin not help jamaintmed in dropbox, or doi:10.1001/jamainternmed.2018.2259) Details: -- 497 patients with symptomatic urinary stones <9 mm in diameter , lodged in the ureter as demonstrated by CT scanning, were randomized to tamsulosin 0.4 mg vs placebo for 28 days, from 2012 to 2016 -- mean age 41, 27% female, 23% nonwhite, 30% personal history of kidney stones, 25% family history of kidney stones, 69% of the stones were in the distal ureter or ureterovesical junction -- stone size: 18% were 1-2 mm, 56% 3-4 mm, 21% 5-6 mm, 5% 7-8 mm (mean diameter 3.8 mm); hydronephrosis on CT in 74%, multiple stones in 38% -- primary outcome was stone passage based on CT visualization or capture by the study participant by day 28 Results: -- stone passage rates were 49.6% in the tamsulosin group vs 47.3% in the ...

alpha blockers help with ureteral stone passage

A recent meta-analysis/systematic review confirmed that a -blockers are efficacious in the treatment of patients with ureteral stones  (see  kidney stone alpha blockers review bmj2016 in dropbox , or  doi.org/10.1136/bmj.i6112 ). details: --55 unique RCTs, with 5990 randomized patients, mostly in European and Asian subjects. Mean stone size 5.7 mm, tamsulosin was the  a -blocker in 40 studies, mean follow-up of 28 days --primary outcome: proportion of patients who passed their stone --secondary outcomes: time to passage of stone, number of pain episodes, and proportion of patients who had surgery/were admitted to hospital/experienced adverse events results: -- a -blockers  facilitated the passage of stone, with risk ratio (RR)=1.49 (1.39-1.61), a 49% higher likelihood of stone passage (moderate quality  evidence)         --the pooled risk difference was 0.27, meaning that ...

interventions to prevent recurrent kidney stones

the Am College of Physicians just released a clinical practice guideline on interventions to prevent recurrent kidney stones (see  kidney stone secondary prevention AIM 2014 in dropbox, or  doi:10.7326/M13-2908 ​). background: --13% of men and 7% of women get kidney stones, and 35-50% have recurrence within 5 years without treatment --80% are calcium oxalate or calcium phosphate or both --dietary efforts include increasing water intake, reducing dietary oxalate, reducing dietary animal protein and other purines, and maintaining normal calcium intake results of this systematic review: --1 good quality and 28 fair-quality trials found insufficient evidence that assessing stone composition, or blood/urine chemistries reduces recurrences --80 fair-quality trials of dietary interventions have found that:          --increased fluid intake, reduced soft drink intake (esp soda acidified by phosphor...

kidney stone predictive model

a recent study developed a clinical prediction rule for uncomplicated ureteral stones (see  kidney stone predictive model bmj 2014  or doi: 10.1136/bmj.g2191).  there were 2 components to the study. first was a retrospective observational study to develop the screening tool, a random selection of 1040 adults (derivation cohort) who underwent non-contrast CT for suspected uncomplicated kidney stone from 2005 to 2010. their data was used to derive the top five factors associated with stones analysis and ascribe points reflecting their importance (see STONE score below). the second study was the validation study, 491 patients where the ER physicians felt that the patient presentation was consistent with ureteral stone.     --for the observational component: the five key factors were -- male sex, short duration of pain, non-black race, presence of nausea or vomiting, and microsopic hematuria.     --in the derivation and the validation co...